0
Deep & Emerging Tech·September 22, 2026·1 min read

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Share

A GLP-1/GIP like Viking’s VK2735 that maintains weight loss with monthly dosing would shift obesity treatment from high-friction chronic care toward a more consumer-like cadence. Healthcare and wellness operators should be modeling demand, supply, and reimbursement around lower-touch regimens that still drive durable outcomes.